Serum BPIFB4 levels classify health status in long-living individuals

Francesco Villa, Alberto Malovini, Albino Carrizzo, Chiara C. Spinelli, Anna Ferrario, Anna Maciag, Michele Madonna, Riccardo Bellazzi, Luciano Milanesi, Carmine Vecchione, Annibale A. Puca

Research output: Contribution to journalArticlepeer-review


Background: People that reach extreme ages (Long-Living Individuals, LLIs) are object of intense investigation for increase/decrease of genetic variant frequencies, genetic methylation levels, protein abundance in serum and tissues. The aim of these studies is the discovery of the mechanisms behind LLIs extreme longevity and the identification of markers of well-being. We have recently associated a BPIFB4 haplotype (LAV) with exceptional longevity under a homozygous genetic model, and identified that CD34+ of LLIs subjects express higher BPIFB4 transcript as compared to CD34+ of control population. It would be of interest to correlate serum BPIFB4 protein levels with exceptional longevity and health status of LLIs. Methods: Western blots on cellular medium to detect BPIFB4 secretion in transfected HEK293T cells with plasmid carrying BPIFB4 and ELISA on LLIs serum to detect BPIFB4 levels. Results: Here we show that BPIFB4 is a secreted protein and its levels are increased in serum of LLIs, and high BPIFB4 levels classify their health status. Conclusions: Serum BPIFB4 protein levels classify longevity and health status in LLIs. Further studies are required to evaluate the possible role of BPIFB4 in monitoring disease progression.

Original languageEnglish
Article number27
JournalImmunity and Ageing
Issue number1
Publication statusPublished - Dec 15 2015


  • BPIFB4
  • CD34
  • Methylation
  • Vascular ageing

ASJC Scopus subject areas

  • Immunology
  • Ageing


Dive into the research topics of 'Serum BPIFB4 levels classify health status in long-living individuals'. Together they form a unique fingerprint.

Cite this